RÉSUMÉ
This study investigated the impact of various Ge132 (Bis-carboxyethyl germanium sesquioxide) concentrations on frozen bovine semen. Ejaculates from three bulls were pooled and divided into six groups, each one with different Ge132 concentrations (0, 500, and 1000 µg/mL) and each group was incubated in different conditions (33°C for 30 min (D: D0, D500, and D1000), and the other was immediately cooled to 4°C (R: R0-control; R500 and R1000)). Thawed semen was evaluated for sperm characteristics by CASA and flow cytometer. Results showed better motility in the immediate cooling group without Ge132 compared with high Ge132 concentrations. Values for total motility dropped after 5 and 60 min in groups with high Ge132 levels and some control groups. Linearity increased with 1000 µg/mL Ge132, while straightness differed between moments in multiple groups. Membrane integrity was higher in a control group and certain Ge132 groups. Lower O2 - generation occurred without Ge132. After oxidative stress induction, lipid peroxidation intensity increased with arachidonic acid, but D1000 had lower peroxidation than R0. Overall, Ge132 appears to have provided protection against PLM when subjected to oxidative stress, since even at high concentrations it maintained sperm metabolism.
Sujet(s)
Antioxydants , Cryoconservation , Conservation de semence , Mobilité des spermatozoïdes , Spermatozoïdes , Animaux , Mâle , Bovins , Cryoconservation/médecine vétérinaire , Cryoconservation/méthodes , Conservation de semence/médecine vétérinaire , Conservation de semence/méthodes , Spermatozoïdes/effets des médicaments et des substances chimiques , Antioxydants/pharmacologie , Mobilité des spermatozoïdes/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Cryoprotecteurs/pharmacologie , Peroxydation lipidique/effets des médicaments et des substances chimiques , Germanium/pharmacologie , Sperme/effets des médicaments et des substances chimiques , Analyse du sperme/médecine vétérinaireRÉSUMÉ
This study evaluated the use of the GnRH agonist hormone, deslorelin, to control the follicular population before initiating multiple ovulation and embryo transfer (MOET) treatment. Twenty-four cross-bred Santa Inês ewes, aged between 2 and 4 years, were randomly assigned to either a control group (n = 11) or a treated group (n = 13). All ewes received an intravaginal device containing 60 mg of medroxyprogesterone acetate on day 0, and a new device on day 7, which remained in place until day 14. Additionally, the ewes were administered 125 µg of cloprostenol on day 7. The superovulatory treatment involved administering 200 mg of pFSH, divided into eight decreasing doses at 12-h intervals starting on day 12. On day 14, 300 IU of eCG was administered. In the deslorelin group, three doses of 100 µg of deslorelin were administered starting on day 3 after the insertion of the vaginal device, with subsequent doses given at 72-h and 144-h intervals. Natural mating was performed 36 h after the removal of the progesterone implant using males with proven fertility. Embryo collection took place on the 6th day after mating, and the recovered structures were quantified and evaluated for quality and developmental stage. Transrectal ultrasonography was conducted on days 12, 16 and 21 to evaluate the ovaries, specifically to assess the ovarian follicular population and the presence of the corpus luteum. Ewes in the control group had higher embryo recovery rates (p < .01) compared to the treated group (5.2 ± 0.8 vs. 1.1 ± 0.8), with differences observed primarily in the number of morulae. The number of corpus luteum observed during the laparotomy on day 21 was significantly higher (p < .01) in the control group (10.44 vs. 4.5 corpus luteum per ewe). Yet, the treated group had a significantly higher number of follicles (p < .05) on the first day of pFSH application (5.5 vs. 3.0 follicles per ewe). In conclusion, although the inclusion of deslorelin in the superovulation protocol resulted in increased synchronization of oestrus and follicle number, it did not lead to an increase in the number of corpus luteum or harvested embryos.
Sujet(s)
Transfert d'embryon , Hormone folliculostimulante , Superovulation , Pamoate de triptoréline , Animaux , Femelle , Pamoate de triptoréline/analogues et dérivés , Pamoate de triptoréline/pharmacologie , Pamoate de triptoréline/administration et posologie , Superovulation/effets des médicaments et des substances chimiques , Hormone folliculostimulante/pharmacologie , Hormone folliculostimulante/administration et posologie , Transfert d'embryon/médecine vétérinaire , Cloprosténol/pharmacologie , Cloprosténol/administration et posologie , Grossesse , Ovaire/effets des médicaments et des substances chimiques , Follicule ovarique/effets des médicaments et des substances chimiques , Ovis aries , Ovis/physiologie , Hormone de libération des gonadotrophines/pharmacologie , Hormone de libération des gonadotrophines/administration et posologie , Acétate de médroxyprogestérone/pharmacologie , Acétate de médroxyprogestérone/administration et posologieRÉSUMÉ
The aim of this study was to assess the addition of 2% sodium caseinate in a commercial egg yolk-based medium in frozen ovine semen. Eight Dorper males were used for the study. The ejaculate was divided into two portions and frozen without (G1) or with the addition of 2% sodium caseinate (G2). Kinetic parameters were evaluated using CASA (computer-assisted sperm analysis), and membrane and acrosome integrity as well as oxidative stress were assessed using flow cytometry. After thawing, a thermoresistance test was conducted at time points T0 and T90. For the fertility test, 100 ewes were inseminated with semen from two rams selected based on in vitro parameters, one with good post-thaw quality (+70% total motility) and the other with low post-thaw quality (-55% total motility). For the fertility test, the females were divided into 4 groups for insemination: low-quality ram without caseinate (GBS = 25) and with caseinate (GBC = 25), and high-quality ram without caseinate (GAS = 25) and with caseinate (GAC = 25). Regarding the results of sperm kinetics, there was a statistically significant difference in the parameters of average path velocity (VAP) and curvilinear velocity (VCL) between the group frozen with BotuBov and the group with added caseinate. At time point T90, straight-line velocity maintained a trend (p < .06), with BotuBov® (BB group) being superior to caseinate this time, and in the linearity parameter, caseinate was superior to BotuBov®. Flow cytometry analysis showed no difference between any of the evaluated tests. In the fertility test, there was no statistically significant difference in the pregnancy rate between the BotuBOV® group (23%, 11/48) and the sodium caseinate group (BC group) (33%, 17/52), and no differences were observed in the male versus diluent interaction (p = .70). In conclusion, sodium caseinate supplementation did not influence sperm kinetic parameters and the fertility of sheep.
Sujet(s)
Caséines , Cryoconservation , Insémination artificielle , Analyse du sperme , Conservation de semence , Mobilité des spermatozoïdes , Animaux , Conservation de semence/médecine vétérinaire , Conservation de semence/méthodes , Mâle , Femelle , Cryoconservation/médecine vétérinaire , Cryoconservation/méthodes , Insémination artificielle/médecine vétérinaire , Caséines/pharmacologie , Analyse du sperme/médecine vétérinaire , Grossesse , Mobilité des spermatozoïdes/effets des médicaments et des substances chimiques , Spermatozoïdes/effets des médicaments et des substances chimiques , Spermatozoïdes/physiologie , Cryoprotecteurs/pharmacologie , Sperme/effets des médicaments et des substances chimiques , Fécondité/effets des médicaments et des substances chimiques , Ovis , Ovis ariesRÉSUMÉ
One of the factors responsible for less pregnancy rates is the use of frozen semen in sheep due to the oxidative stress created by the process. The aim of this experiment was to test the effects of adding coenzyme Q-10 (CoQ10) to the seminal extender on sperm quality and the pregnancy rate of sheep. In this study, ejaculates from eight Dorper rams of reproductive age were used and tested in four treatments: Control (pure BotuBov®), C1 (175⯵M of CoQ10), C3 (350⯵M of CoQ10), and C7 (700⯵M of CoQ10). Samples were collected in triplicate from each animal, and sperm analysis was performed by CASA after thawing at 0â¯h and 2â¯h. The samples were also analyzed by flow cytometry for plasma and acrosomal membrane integrity, stability, lipid peroxidation, mitochondrial potential, and superoxide anion production. In total, 198 ewes were inseminated by laparoscopy and divided into two groups: control (n=98) and C7 (n=100). Pregnancy diagnosis was performed at 30 days. Coenzyme Q10 proved to be safe for semen cryopreservation, not altering sperm kinetic values between the groups post-thawing. In flow cytometry, the C1 and C7 groups achieved a better index of plasma membrane integrity and membrane stability (P<0.05). A increased pregnancy rate was observed in C7 (52â¯%) compared to the control (38â¯%). In conclusion, coenzyme Q10 assists in the cryopreservation process, protecting the sperm cell and improving pregnancy rates in ewes.